Investors / United States / NEA
NEA
Venture capital · Menlo Park, CA, United States · North America
NEA is a venture capital firm established in 1977 that invests in founders across every stage of company building, from idea to IPO. It offers domain expertise in healthcare and technology and works as an active partner to its portfolio companies.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordshealthcaretechnologyventure capitalearly stagegrowth stage
Your fit with NEA
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNEA lists 533 checked portfolio companies on its own site and is named in 102 funding rounds, 51 of them as lead. Its most frequent entry is Series A, 33% of the companies with a known first round. Its largest themes are Healthcare & Biotech (22%), AI & Machine Learning (19%) and Fintech (10%). 79% of its companies are based in United States. It invests most often alongside Andreessen Horowitz, NewView Capital and Kleiner Perkins.
Counts come from funding rounds that name NEA, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not NEA's whole history. Rounds on record name 84 companies; its own site lists 533. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 33% |
| Series B | 27% |
| Growth | 22% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 1 | 0 |
| '18 | 1 | 0 |
| '19 | 2 | 0 |
| '20 | 0 | 0 |
| '21 | 2 | 1 |
| '22 | 4 | 2 |
| '23 | 1 | 0 |
| '24 | 5 | 2 |
| '25 | 45 | 26 |
| '26 | 40 | 20 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 100th | 528 companies |
| Recent activity | 100th | 44 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 83th | 13% of companies confirmed by a round |
| Sector focus | 22th | 22% in its largest sector |
| Reach | 100th | 24 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 22% | 15% |
| AI & Machine Learning | 19% | 18% |
| Fintech | 10% | 12% |
| Enterprise Software | 9% | 8% |
| E-commerce & Marketplaces | 6% | 6% |
| Cybersecurity | 6% | 4% |
| Education | 6% | 7% |
| Media & Entertainment | 4% | 4% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Andreessen Horowitz | 36 |
| NewView Capital | 24 |
| Kleiner Perkins | 19 |
| Salesforce Ventures | 19 |
| Y Combinator | 19 |
| Sequoia Capital | 18 |
| Accel | 17 |
| Index Ventures | 16 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers49793%
- No longer answers00%
- Points to another company367%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Andreessen Horowitz
Compare NEA head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with NEA| Date | Company | Stage |
|---|---|---|
| 6 Oct 2026 | Series B Led | |
| 5 Oct 2026 | Series B | |
| 23 Sept 2026 | Series A Led | |
| 15 Sept 2026 | Series C+ | |
| 10 Sept 2026 | Series C+ Led | |
| 9 Sept 2026 | Series A | |
| 17 Aug 2026 | Series B | |
| 13 Aug 2026 | Series C+ |
Round details for NEA
Amounts, full round histories and every co-investor in NEA's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
533 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| 23andMe sells DNA testing kits and subscription plans that report on a person's genetic ancestry and genetic health risks. | Healthcare & BiotechConsumer | Portfolio page | ||
| The company provides services for students applying to study abroad in countries such as the UK, Australia, and the US. | Education | Portfolio page | ||
| 858 Therapeutics is a clinical-stage biotechnology company developing therapies designed to target tumor dependencies in DNA damage response pathways. | Healthcare & Biotech | Portfolio page | ||
| Abcuro develops therapies for autoimmune diseases and cancer. | Healthcare & Biotech | Portfolio page | ||
| Acadia Pharmaceuticals advances treatment in neurological disorders and rare diseases with novel therapies | Healthcare & Biotech | Portfolio page | ||
| Accordance provides software for tax, audit, accounting, and advisory teams to manage their work and clients | FintechAI & Machine Learning | Sept 2025Seed | Funding round | |
| Acquia provides a digital experience platform for managing content, community, and commerce | EducationHealthcare & Biotech | Portfolio page | ||
| Acrivon is developing targeted therapies to improve the lives of patients. | Healthcare & Biotech | Portfolio page | ||
AI & Machine LearningSpace & Defense | Portfolio page | |||
| Adaptimmune is involved in cell therapies against cancer. | Healthcare & Biotech | Portfolio page | ||
| Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. | Healthcare & Biotech | Portfolio page | ||
| AdZen AI creates conversational ads that engage people directly in the content they are interested in and drive measurable results across premium publishers, AI platforms and consumer-generated content. | AI & Machine LearningMedia & Entertainment | Feb 2026Seed | Funding round | |
| Aera understands, recommends, acts, and learns to help businesses make decisions and automate processes | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Aerospike provides a multi-model NoSQL database server and other related products and services | Developer ToolsDeveloper Tools | Portfolio page | ||
| Cowboy Space Corporation builds a power grid in outer space for artificial intelligence using satellites and rockets | Space & DefenseAI & Machine Learning | Apr 2025Series A | Funding round | |
| Datavant securely connects, protects, and activates health data across the healthcare ecosystem through a data collaboration platform | Healthcare & Biotech | Portfolio page | ||
| Affinia Therapeutics develops gene therapies, specifically adeno-associated virus (AAV) gene therapy, for diseases such as BAG3-associated dilated cardiomyopathy | Healthcare & Biotech | Oct 2025Series C+ | Page + round | |
| The company develops and manufactures autonomous, solar-powered robots for outdoor use in various industries, including agriculture and construction. | AI & Machine LearningRobotics & Hardware | Portfolio page | ||
| AirWorks provides AI-enabled field intelligence solutions for engineering project workflows | AI & Machine LearningCybersecurity | Portfolio page | ||
| AISquared builds, deploys, and governs AI applications across existing systems | AI & Machine LearningEnterprise Software | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- nea.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 20 Dec 2012
- Companies checked
- 533
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get NEA's profile as data
Pull NEA's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/nea.com
# also
GET /v1/firms/nea.com/portfolio
GET /v1/firms/nea.com/coinvestors
GET /v1/firms/nea.com/news